Highlight from recent cancer literature

摘要：

EpCAM-directed immunotherapy:a novel treatment opportunity for patients with pancreatic cancer Pancreatic cancer is notorious for its early metastasis and natural resistance to conventional chemotherapy and radiation.However,a recent study by Heeschen and colleagues provides new hope for these patients.The authors reported that epithelial cell adhesion molecule (EpCAM; CD326)-directed immunotherapy effectively eliminates circulating and/or isolated pancreatic cancer stem cells (CSCs) and may be a novel treatment strategy to improve the survival of patients with pancreatic cancer.

机标关键词：Pancreatic cancer、cancer stem cells、adhesion molecule、epithelial cell

所属期刊栏目：31

分类号：R73;R5

在线出版日期：2013-09-04（万方平台首次上网日期，不代表论文的发表时间）

页数：共2页

页码：119-120